Search

everythinglearnresearchcommunity

for

Search:↓

PEVIII is a promising treatment for Pseudomonas aeruginosa keratitis.

DPCP alone is more effective and safer for treating chronic extensive alopecia areata than combining it with anthralin.

Topical immunotherapy is more effective than dapsone for treating severe alopecia areata.

A woman with a drug allergy to anakinra was successfully desensitized, allowing her to continue treatment without allergic reactions.

Microneedle patches with alpha-arbutin and resveratrol can effectively reduce skin pigmentation without irritation.

Diphenylcyclopropenone (DPCP) is more effective than anthralin for treating resistant alopecia areata.

Polymeric micelle nanocarriers deliver adapalene more effectively to hair follicles than commercial products.

New dissolving and implantable microneedle patches have been created for a long-lasting, non-invasive delivery of the drug finasteride.

The document concluded that various dermatological treatments have different effectiveness and side effects, with some causing irritation, allergic reactions, or systemic effects.

Finasteride is more stable in sunlight than Diclofenac and Naproxen.

Triptolide effectively and safely reduces actinic keratosis lesions in mice.

Diphenylcyclopropenone is effective and safe for treating severe alopecia areata in children, with maintenance therapy reducing relapse risk.

The targeted nanohybrids effectively reduced psoriasis symptoms and improved skin health.

The patches could quickly deliver epilepsy treatment and reduce seizures.

Pregnenolone might help manage movement issues caused by Parkinson's disease treatment without reducing the medicine's effectiveness.

Diphencyprone (DPC) is an effective and safe long-term treatment for alopecia areata, especially with maintenance therapy.

A man developed severe skin reactions after using a treatment for hair loss.

DPCP may be safe for treating alopecia during pregnancy, but more research is needed.

Diphencyprone can cause unexpected and possibly permanent vitiligo.

Dupilumab is effective and safe for treating moderate-to-severe atopic dermatitis in adolescents.

Dermatological treatments can have significant side effects, including allergic reactions, sexual dysfunction, and increased cancer risk.

Geranyl acetate can protect skin cells from damage and inflammation caused by para-phenylenediamine.

DS-2325a is safe and well-tolerated, supporting further development for Netherton Syndrome treatment.

PCE-DP brightens skin and promotes hair growth by enhancing cell growth and reducing melanin uptake.

Dupilumab for atopic dermatitis can cause mild skin issues in some patients.

Dapsone gel 5% is effective and safe for treating acne.